Live
Funding 1 min read

Dutch Chip Company Raises Over EUR 200 million—EU’s New Scaling Fund and Danish EIFO Involved

Euclyd has raised more than EUR 200 million in a Series A round led by Samsung and the Scaleup Europe Fund, with participation from Danish EIFO.

Image: Shifter

Euclyd, a Dutch chip company, has raised over EUR 200 million in a Series A funding round. This substantial amount was led by Samsung and the Scaleup Europe Fund.

The investment is aimed at advancing Euclyd's development of energy-efficient AI chips for inference, receiving backing from significant players like Samsung and the Danish EIFO, reflecting strong interest in semiconductor technology.

The funding will empower Euclyd to progress in the semiconductor market, establishing itself at the forefront of the evolving AI chip industry in Europe.

Reporting sources

Where this story comes from

1 reference

The facts above are grounded in the original reporting linked here. Open the publisher story for its complete context.

ShifterNO source · English rendering Open source

Dutch Chip Company Raises Over EUR 200 million—EU’s New Scaling Fund and Danish EIFO Involved

The available publisher preview does not add detail beyond this brief. Open the original report for its full context.

Related coverage

Story history

No reviewed connections found in the current history window.

About this history review

The link graph’s cryptographic signature was verified. This proves integrity, not the truth of every claim or complete archive coverage.

Graph updated . Only articles retained in the public archive are included.

Open technical link data
Method & transparencyHow this brief was selected and checked
Editorial priority7 / 10

Priority

Source coverageSingle-source report

Single-source report

ConfidenceLimited

45 / 100 · one source

Source basis

Grounded in the publisher material listed below.

Confirmation

No second independent source has been matched to this story yet.

Selection

Selected for publication after relevance, freshness and editorial-quality checks.

Selection factors

  • 1 independent source
  • 1 concrete event indicator
  • editorial priority

Source monitoring: 99% recent availability · No source-health warnings. The original publisher remains the authoritative source for the full report.